Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
84.11
+5.14 (6.51%)
Jun 29, 2026, 2:12 PM EDT - Market open
Hinge Health Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for Hinge Health stock have an average target of 75.06, with a low estimate of 45 and a high estimate of 95. The average target predicts a decrease of -10.76% from the current stock price of 84.11.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Hinge Health stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 8 | 8 | 8 |
| Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Reiterates $80 → $90 | Buy | Reiterates | $80 → $90 | +7.00% | Jun 23, 2026 |
| Robert W. Baird | Robert W. Baird | Hold Maintains $55 → $65 | Hold | Maintains | $55 → $65 | -22.72% | Jun 17, 2026 |
| Raymond James | Raymond James | Buy Maintains $70 → $80 | Buy | Maintains | $70 → $80 | -4.89% | Jun 15, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $65 → $76 | Buy | Reiterates | $65 → $76 | -9.64% | Jun 15, 2026 |
| KeyBanc | KeyBanc | Buy Reiterates $75 → $90 | Buy | Reiterates | $75 → $90 | +7.00% | Jun 12, 2026 |
Financial Forecast
Revenue This Year
819.72M
from 587.86M
Increased by 39.44%
Revenue Next Year
1.03B
from 819.72M
Increased by 25.37%
EPS This Year
2.59
from 2.62
Decreased by -1.33%
EPS Next Year
3.37
from 2.59
Increased by 30.23%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 828.7M | 1.1B | |
| Avg | 819.7M | 1.0B | |
| Low | 799.7M | 961.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 41.0% | 32.4% | |
| Avg | 39.4% | 25.4% | |
| Low | 36.0% | 17.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.86 | 3.75 | |
| Avg | 2.59 | 3.37 | |
| Low | 2.06 | 2.58 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.2% | 45.1% | |
| Avg | -1.3% | 30.2% | |
| Low | -21.4% | -0.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.